Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus sublingual minoxidil for female pattern hair loss
RBR-5sdqcgkPhase 3Recruiting
- Sponsor
- Hospital Moriah
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of minoxidil in Female Pattern Hair Loss (FPHL) and androgenetic alopecia (AGA) (2 arms), sponsored by Hospital Moriah. Started Jul 2023; status: recruiting.
02
Drugs
minoxidil
03
Conditions
Female Pattern Hair Loss (FPHL)androgenetic alopecia (AGA)
Beyond the preview
Go deeper on RBR-5sdqcgk.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5sdqcgk.